The PHITT trial is an over-arching study for patients with Hepatoblastoma (HB) and
Hepatocellular Carcinoma (HCC). This trial will use a risk-adapted approach to the treatment
of children diagnosed with HB.
Children with HCC will be included as a separate cohort.
Phase:
Phase 3
Details
Lead Sponsor:
University of Birmingham
Collaborators:
Fundació Institut Germans Trias i Pujol Medical University of Gdansk University Hospital Munich University Hospital Tuebingen University Hospital, Bonn University of Kiel University of Newcastle Upon-Tyne University of Padova University of Padua